SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike proteinEduardo A. Albornoz, Trent M. Woodruff, Nias Y. G. Peng et al.|Molecular Psychiatry|2022Cited by 178
Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobodyAlejandro Rojas‐Fernández, Ronald Jara, Daniel Watterson et al.|Scientific Reports|2021Cited by 52
A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variantsNaphak Modhiran, Daniel Watterson, Simon Lauer et al.|iScience|2023Cited by 17
Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity NanobodyAlejandro Rojas‐Fernández, Ronald Jara, Daniel Watterson et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 16
SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike-ACE2 receptor interactionEduardo A. Albornoz, Trent M. Woodruff, Alberto A. Amarilla et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 8